Furthermore, in the breast cancer model of MMTV-PyMT transgenic mice, Guerriero et al. found that class IIa HDAC inhibitors (TMP195) recruit and differentiate macrophages as well as promote their conversion into hyperphagocytic macrophages, thereby reducing tumor burden and tumor lung metastasis [121]. The gene discussed is HDAC9; the disease is neoplasm.